This study demonstrated that in patients with adenomyosis, treatment with LNG-IUD, compared with oral norethindrone, was associated with a lower risk of PID and severe anemia (Hb < 10 g/dL) but a higher risk of BV. This evidence concerns the gene GSTM1 and anemia.